CRP and blood coagulation disease: We previously showed that initial values of routinely collected biomarkers including C-reactive protein (CRP), D-dimer, and ferritin on hospital admission with COVID-19 were increased in Black and South Asian patients, potentially reflecting increased systemic inflammation, coagulopathy, and immune dysregulation.6